236 related articles for article (PubMed ID: 25451568)
41. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
42. Anti-osteosarcoma effects and mechanisms of 4-O-amino-phenol-4'-demethylepipodophyllotoxin ether.
Yang TM; Guo SF; Chen CR; Zhang XY; Li WG
J Pharm Pharmacol; 2008 Feb; 60(2):179-88. PubMed ID: 18237465
[TBL] [Abstract][Full Text] [Related]
43. Apigenin induces apoptosis through mitochondrial dysfunction in U-2 OS human osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth in vivo.
Lin CC; Chuang YJ; Yu CC; Yang JS; Lu CC; Chiang JH; Lin JP; Tang NY; Huang AC; Chung JG
J Agric Food Chem; 2012 Nov; 60(45):11395-402. PubMed ID: 23066961
[TBL] [Abstract][Full Text] [Related]
44. Cell cycle arrest and apoptosis induced by aspidin PB through the p53/p21 and mitochondria-dependent pathways in human osteosarcoma cells.
Wan D; Jiang C; Hua X; Wang T; Chai Y
Anticancer Drugs; 2015 Oct; 26(9):931-41. PubMed ID: 26181229
[TBL] [Abstract][Full Text] [Related]
45. Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells.
Yousuf I; Arjmand F; Tabassum S; Toupet L; Khan RA; Siddiqui MA
Dalton Trans; 2015 Jun; 44(22):10330-42. PubMed ID: 25970097
[TBL] [Abstract][Full Text] [Related]
46. Nona-copper(II)-containing 18-tungsto-8-arsenate(III) exhibits antitumor activity.
Zhou Z; Zhang D; Yang L; Ma P; Si Y; Kortz U; Niu J; Wang J
Chem Commun (Camb); 2013 Jun; 49(45):5189-91. PubMed ID: 23628910
[TBL] [Abstract][Full Text] [Related]
47. Copper(II) mixed chelate compounds induce apoptosis through reactive oxygen species in neuroblastoma cell line CHP-212.
Gutiérrez AG; Vázquez-Aguirre A; García-Ramos JC; Flores-Alamo M; Hernández-Lemus E; Ruiz-Azuara L; Mejía C
J Inorg Biochem; 2013 Sep; 126():17-25. PubMed ID: 23727332
[TBL] [Abstract][Full Text] [Related]
48. Baicalein induces human osteosarcoma cell line MG-63 apoptosis via ROS-induced BNIP3 expression.
Ye F; Wang H; Zhang L; Zou Y; Han H; Huang J
Tumour Biol; 2015 Jun; 36(6):4731-40. PubMed ID: 25618603
[TBL] [Abstract][Full Text] [Related]
49. Induction of G2/M phase cell cycle arrest and apoptosis by ginsenoside Rf in human osteosarcoma MG‑63 cells through the mitochondrial pathway.
Shangguan WJ; Li H; Zhang YH
Oncol Rep; 2014 Jan; 31(1):305-13. PubMed ID: 24173574
[TBL] [Abstract][Full Text] [Related]
50. Anticancer effect of thalidomide in vitro on human osteosarcoma cells.
Zhu J; Yang Y; Liu S; Xu H; Wu Y; Zhang G; Wang Y; Wang Y; Liu Y; Guo Q
Oncol Rep; 2016 Dec; 36(6):3545-3551. PubMed ID: 27748909
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and Pharmacological Evaluation of σ2 Receptor Ligands Based on a 3-Alkoxyisoxazole Scaffold: Potential Antitumor Effects against Osteosarcoma.
Shi JJ; Jia KH; Sun H; Gunosewoyo H; Yang F; Tang J; Luo J; Yu LF
ChemMedChem; 2021 Feb; 16(3):524-536. PubMed ID: 32964625
[TBL] [Abstract][Full Text] [Related]
52. Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo.
Wu Z; Ma C; Shan Z; Ju Y; Li S; Zhao Q
J BUON; 2013; 18(4):1032-7. PubMed ID: 24344034
[TBL] [Abstract][Full Text] [Related]
53. Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells.
Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
Biochem Biophys Res Commun; 2013 Sep; 439(2):179-86. PubMed ID: 23994633
[TBL] [Abstract][Full Text] [Related]
54. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
55. Benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC)-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of caspase-3, mitochondria dysfunction and nitric oxide (NO) in human osteogenic sarcoma U-2 OS cells.
Wu CL; Huang AC; Yang JS; Liao CL; Lu HF; Chou ST; Ma CY; Hsia TC; Ko YC; Chung JG
J Orthop Res; 2011 Aug; 29(8):1199-209. PubMed ID: 21374707
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of quercetin as a potential drug in osteosarcoma treatment.
Berndt K; Campanile C; Muff R; Strehler E; Born W; Fuchs B
Anticancer Res; 2013 Apr; 33(4):1297-306. PubMed ID: 23564766
[TBL] [Abstract][Full Text] [Related]
57. Anticancer effects of zoledronic acid against human osteosarcoma cells.
Kubista B; Trieb K; Sevelda F; Toma C; Arrich F; Heffeter P; Elbling L; Sutterlüty H; Scotlandi K; Kotz R; Micksche M; Berger W
J Orthop Res; 2006 Jun; 24(6):1145-52. PubMed ID: 16602111
[TBL] [Abstract][Full Text] [Related]
58. Saurolactam Inhibits Proliferation, Migration, and Invasion of Human Osteosarcoma Cells.
Li Z; Liu H; Li B; Zhang Y; Piao C
Cell Biochem Biophys; 2015 Jul; 72(3):719-26. PubMed ID: 25627547
[TBL] [Abstract][Full Text] [Related]
59. Novel quinolone CHM-1 induces apoptosis and inhibits metastasis in a human osterogenic sarcoma cell line.
Hsu SC; Yang JS; Kuo CL; Lo C; Lin JP; Hsia TC; Lin JJ; Lai KC; Kuo HM; Huang LJ; Kuo SC; Wood WG; Chung JG
J Orthop Res; 2009 Dec; 27(12):1637-44. PubMed ID: 19557855
[TBL] [Abstract][Full Text] [Related]
60. In vitro antitumor activity of the ethyl acetate extract of Potentilla chinensis in osteosarcoma cancer cells.
Wan G; Tao JG; Wang GD; Liu SP; Zhao HX; Liang QD
Mol Med Rep; 2016 Oct; 14(4):3634-40. PubMed ID: 27573158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
